Tech Company Financing Transactions
Qsimulate Funding Round
On 11/29/2023, Qsimulate received $2.5 million in funding from 2xN, Kyoto University Innovation Capital (Kyoto iCAP) and UTokyo Innovation Platform.
Transaction Overview
Company Name
Announced On
11/29/2023
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support its business centered on its quantum physics-based drug-discovery platform, QSP Life.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
20 Guest St, STE 101
Boston, MA 02135
USA
Boston, MA 02135
USA
Phone
Website
Email Address
Overview
Developer of quantitative simulation tools designed to help in quantum molecular simulations in the cloud. The company's cloud-based simulation tools help the chemical and pharmaceutical industries solve the industrial-scale problems they face and the platform automates workflows, freeing computational scientists from mundane tasks to enhance productivity, enabling clients to accelerate their research and development process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Toru Shiozaki
VP - Product Management
David Pearlman
Browse more venture capital transactions:
Prev: 11/29/2023: ISMS venture capital transaction
Next: 11/29/2023: BeCause - It's Diff venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs